New Products & Services

Raritan, NJ-The FDA has approved a once-a-day liquid formulation of the fluoroquinone antibiotic levofloxacin (Levaquin), from Ortho-McNeil Pharmaceutical, Inc. Levofloxacin is indicated for the treatment of a number of infections, including complicated and uncomplicated urinary tract infections, chronic bacterial prostatitis, and acute pyelonephritis.

Related Videos

Related Content

Advertisement

April 14th 2025

Coding Q&A: How to bill for second-generation stone device

Jonathan Rubenstein, MD Mark Painter

Jonathan Rubenstein, MD, and Mark Painter answer a question regarding coding for use of the second-generation Calyxo CVAC system.

March 21st 2024

Health policy in urology: 2024 AUA Advocacy Summit recap

Urology Times staff

In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy and recap the AUA's recent Annual Urology Advocacy Summit.

March 21st 2025

Money Matters: How to cope with market volatility in 2025

Jeff Witz, CFP

"If you determine you can invest in a volatile environment, the best approach is to do so over a period of time," writes Jeff Witz, CFP.

August 28th 2023

How APPs can bridge the gap in urologist shortages

Urology Times staff

In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.

February 19th 2025

Level of service for vasectomy prompts coding confusion

Jonathan Rubenstein, MD Mark Painter

"With the requirements for an E/M code as noted above, we agree with you that the supporting documentation, if appropriately documented, would support a level 3 outpatient visit for a visit regarding counseling for contraception or family planning," write Jonathan Rubenstein, MD, and Mark Painter.

February 10th 2025

Trends in urology: Arpeet Shah, MD, on challenges and opportunities in 2025

Arpeet Shah, MD

Arpeet Shah, MD, highlights the shift toward precision medicine, ongoing work force challenges, the integration of AI, and more.

Related Content

Advertisement

April 14th 2025

Coding Q&A: How to bill for second-generation stone device

Jonathan Rubenstein, MD Mark Painter

Jonathan Rubenstein, MD, and Mark Painter answer a question regarding coding for use of the second-generation Calyxo CVAC system.

March 21st 2024

Health policy in urology: 2024 AUA Advocacy Summit recap

Urology Times staff

In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy and recap the AUA's recent Annual Urology Advocacy Summit.

March 21st 2025

Money Matters: How to cope with market volatility in 2025

Jeff Witz, CFP

"If you determine you can invest in a volatile environment, the best approach is to do so over a period of time," writes Jeff Witz, CFP.

August 28th 2023

How APPs can bridge the gap in urologist shortages

Urology Times staff

In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.

February 19th 2025

Level of service for vasectomy prompts coding confusion

Jonathan Rubenstein, MD Mark Painter

"With the requirements for an E/M code as noted above, we agree with you that the supporting documentation, if appropriately documented, would support a level 3 outpatient visit for a visit regarding counseling for contraception or family planning," write Jonathan Rubenstein, MD, and Mark Painter.

February 10th 2025

Trends in urology: Arpeet Shah, MD, on challenges and opportunities in 2025

Arpeet Shah, MD

Arpeet Shah, MD, highlights the shift toward precision medicine, ongoing work force challenges, the integration of AI, and more.